Cathepsin D in breast cancer: Mechanisms and clinical applications, a 1999 overview

Clinica Chimica Acta

Volumn 291, Issue 2, 2000, Pages 157-170

  Rochefort, Henri ^a   Garcia, Marcel ^a   Glondu, Murielle ^a   Laurent, Valérie ^a   Liaudet, Emmanuelle ^a   Rey, Jean Marc ^a   Roger, Pascal ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Breast cancer; Cathepsin D; Cell proliferation; Man 6 P IGFII receptor; Metastasis; Phagocytosis; Prognostic marker; Proteases

Indexed keywords

CATHEPSIN D; COMPLEMENTARY DNA;

BASEMENT MEMBRANE; BREAST CANCER; CELL PROLIFERATION; DISEASE MARKER; METASTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BREAST NEOPLASMS; CATHEPSIN D; HUMANS; TUMOR MARKERS, BIOLOGICAL;

MUS MUSCULUS;

EID: 0034651918     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00226-0     Document Type: Article

References (59)

1. Rochefort H., Capony F., Garcia M., Cavaillès V., Freiss G., Chambon M., Morisset M., Vignon F. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis? J Cell Biochem. 35:1987;17-29.
2. r 52,000 cathepsin-D and poor prognosis in primary human breast cancer. Cancer Res. 49:1989;6008-6014.
3. Spyratos F., Brouillet J.P., Defrenne A., Hacene K., Rouesse J., Maudelonde T., Brunet M., Andrieu C., Desplaces A., Rochefort H. Cathepsin-D: an independant prognostic factor for metastasis of breast cancer. Lancet. 8672:1989;1115-1118.
4. Saftig P., Hetman M., Schmahl W., Weber K., Heine L., Mossmann H., Köster A., Hess B., Evers M., Von Figura K., Peters C. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14:1995;3599-3608.
5. Westley B.R., Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 20:1980;353-362.
6. Rochefort H., Cavaillès V., Augereau P., Capony F., Maudelonde T., Touitou I., Garcia M. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem. 34:1989;77-182.
7. Cavaillès V., Augereau P., Rochefort H. Cathepsin D gene is controlled by a mixed promoter and estrogens stimulate only TATA dependent transcription in breast cancer cells. Proc Natl Acad Sci USA. 90:1993;203-207.
8. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur J Cancer. 28A:1992;1780-1783.
9. Ravdin P.M. Prognostic value of cathepsin-D in breast cancer. Breast Cancer Res Treat. 24:1993;219-226.
10. Cardiff R.D. Cathepsin D and breast cancer: Useful? Hum Pathol. 25:1994;847-848.
11. Roger P., Montcourrier P., Maudelonde T., Brouillet J.P., Pagès A., Laffargue F., Rochefort H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: Correlation with cytosolic assay. Human Path. 25:1994;863-871.
12. Kute T.E., Shao L.-M., Sugg K., Long R.T., Russel G.B., Case L.D. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res. 52:1992;1-6.
13. Ferrandina G., Scambia G., Bardelli F., Panici B., Mancuso S., Messori A. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. Br J Cancer. 76:1997;661-666.
14. Foekens J.A., Look M.P., Bolt-de Vries J., Meijer-van Gelder M., van Putten W.L.J., Klijn J.G.M. Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer. 79:1999;300-307.
15. Pujol P., Daurès J.P., Brouillet J.P., Maudelonde T., Rochefort H., Grenier J. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer. Br J Cancer. 79:1999;909-914.
16. Rochefort H. The prognostic value of Cathepsin-D in breast cancer: A long road to the clinic. Eur J Cancer. 32A:1996;7-8.
17. Garcia D., Derocq D., Pujol P., Rochefort H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene. 5:1990;1809-1814.
18. Liaudet E., Garcia M., Rochefort H. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene. 9:1994;1145-1154.
19. Wu X., Craft N., Raitano A., Chari A., Sawyers C.L. Functional expression cloning identifies cathepsin D as a candidate gene for prostate cancer progression. Abstract no. 878, 89th Annual Meeting of the American Association for Cancer Research, March 28-April 1, 1998, New Orleans, LA, USA.
20. Vignon F., Capony F., Chambon M., Freiss G., Garcia M., Rochefort H. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52k protein. Endocrinology. 118:1986;1537-1545.
21. Stewart A.J., Piggot N.H., May F.E.B., Westley B.R. Mitogenic activity of procathepsin D purified for conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer. 57:1994;715-718.
22. Liaudet E., Derocq D., Rochefort H., Garcia M. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Diff. 6:1995;1045-1052.
23. Johnson M.D., Torri J.A., Lippman M.E., Dickson R.B. The role of cathepsin-D in the invasiveness of human breast cancer cells. Cancer Res. 53:1993;873-877.
24. Brouillet J.P., Spyratos F., Hacene K., Fauque J., Freiss G., Fupont F., Maudelonde T., Rochefort H. Immunoradiometric assay of pro-catepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. Eur J Cancer. 29A:1993;1248-1251.
25. Capony F., Rougeot C., Montcourrier P., Cavaillès V., Salazar G., Rochefort H. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res. 49:1989;3904-3909.
26. Rijnboutt S., Aerts H.M.F.G., Geuze H.J., Tager J.M., Strous G.J. Identification of subcellular compartments involved in biosynthetic processing of cathepsin D. J Biol Chem. 266:1991;4862-4868.
27. Montcourrier P., Mangeat P., Salazar G., Morisset M., Sahuquet A., Rochefort H. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res. 50:1990;6045-6054.
28. Montcourrier P., Mangeat P., Valembois C., Salazar G., Sahuquet A., Duperray C., Rochefort H. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci. 107:1994;2381-2391.
29. Coopman P.J., Do M.T.H., Thompson E.W., Mueller S.C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res. 4:1998;507-515.
30. Griffiths J.R. Are cancer cells acidic? Br J Cancer. 64:1991;425-427.
31. Silver I.A., Murrills R.J., Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages an osteoclasts. Exp Cell Res. 175:1988;266-276.
32. Montcourrier P., Silver I.A., Farnoud R., Bird I., Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin Exp Metast. 15:1997;382-392.
33. Briozzo P., Badet J., Capony F., Pieri I., Montcourrier P., Barritault D., Rochefort H. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res. 194:1991;252-259.
34. Van der Stappen J.W.J., Williams A.C., Maciewicz R.A., Paraskeva C. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer. 67:1996;547-554.
35. Kobayashi H., Schmitt M., Goretzki L., Chucholowski N., Calvete J., Kramer M., Gunzler W.A., Janicke F., Graeff H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (pro-uPA). J Biol Chem. 266:1991;5147-5152.
36. Lenarcic B., Kos J., Dolens I., Locovnik P., Krizaj I., Turk V. Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochem Biophys Res Commun. 154:1988;765-772.
37. Deussing J., Roth W., Saftig P., Peters C., Ploegh H.L., Villadangos J.A. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci USA. 95:1998;4516-4521.
38. Gottesman M.M. The role of proteases in cancer. Seminars in cancer biology. vol. 1:1990;Saunders Scientific Publications, London.
39. Veith F.O., Capony F., Garcia M., Chantelard J., Pujol H., Veith F., Zajdela A., Rochefort H. Release of estrogen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture. Cancer Res. 43:1983;1861-1868.
40. Laurent V., Farnoud M.R., Lucas A., Rougeot C., Garcia M., Rochefort H. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. J Cell Sci. 111:1998;2539-2549.
41. Von Figura K., Hasilik A. Lysosomal enzymes and their receptors. Ann Rev Biochem. 55:1986;167-193.
42. Mathieu M., Rochefort H., Barenton B., Prebois C., Vignon F. Interactions of cathepsin-D and IGF-II on the IGF-II/M6P receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endo. 4:1990;1327-1335.
43. Capony F., Morisset M., Barrett A.J., Capony J.P., Broquet P., Vignon F., Chambon M., Louisot P., Rochefort H. Phosphorylation, glycosylation and proteolytic activity of the 52K estrogen-induced protein secreted by MCF7 cells. J Cell Biol. 104:1987;253-262.
44. Isidoro C., Baccino F.B., Hasilik A. Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer. 70:1997;561-566.
45. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., Jirtle J.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet. 12:1995;2003-2009.
46. Chappell S.A., Walsh T., Walker R.A., Shaw J.A. Lost of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinoma. Brit J Cancer. 75:1997;1324-1329.
47. Rey J.M., Theillet C., Brouillet J.P., Rochefort H. Stable amino acid sequence of the mannose-6-phosphate/insulin-like growth factor II receptor in ovarian carcinomas with loss of heterozygosity and in breast cancer cell lines. Int J Cancer 2000;85: in press.
48. Hankins G.R., De Souza A.T., Bentley R.C., Patel M.R., Marks J.R., Iglehart J.D., Jirtle J.L. M6P/IGFII receptor: a candidate breast tumor suppressor gene. Oncogene. 12:1996;2003-2009.
49. Mathieu M., Vignon F., Capony F., Rochefort H. Estradiol down regulates the mannose-6-phosphate/IGFII receptor gene and induces cathepsin D in breast cancer cells: A receptor saturation mechanism to increase the secretion of lysosomal pro-enzymes. Mol Endocrinol. 5:1991;815-822.
50. De Leon D.D., Terry C., Asmerom Y., Nissley P. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endocrinology. 137:1996;1851-1859.
51. Lemamy G.J., Roger P., Mani J.C., Robert M., Rochefort H., Brouillet J.P. High-affinity antibodies from hen's-egg yolks against human mannose-6-phosphate/insulin-like growth-factor-II receptor (M6P/IGFII-R): characterization and potential use in clinical cancer studies. Int J Cancer. 80:1999;896-902.
52. Diment S., Leech M.S., Stahl P.D. Cathepsin D is membrane-associated in macrophage endosomes. J Biol Chem. 263:1988;6901-6907.
53. Capony F., Braulke T., Rougeot C., Roux S., Montcourrier P., Rochefort H. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp Cell Res. 215:1994;154-163.
54. Zhu Y., Conner G.E. Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem. 269:1994;3846-3851.
55. Glickman J.N., Kornfeld S. Mannose-6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts. J Cell Biol. 123:1993;99-108.
56. Dittmer F., Ulrich E.J., Hafner A., Schmahl W., Meister T., Pohlmann R., von Figura K. Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. J Cell Sci. 112:1999;1591-1597.
57. Fusek M., Vetvicka V. Mitogenic function of human procathepsin D: the role of the propeptide. Biochem J. 303:1994;775-780.
58. Vetvicka V., Vetvickova J., Hilgert I., Voburka Z., Fusek M. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int J Cancer. 73:1997;403-409.
59. Carney D.H., Cunningham D.D. Role of specific cell surface receptors in thrombin-stimulated cell division. Cell. 15:1978;1341-1349.